Alberto Forteza

Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial

Alberto Forteza, Arturo Evangelista, Violeta Sánchez et al. · European Heart Journal · 2015 · 164 citations

Medicine, Cardiology, Pharmacotherapy +17

Vascular Smooth Muscle Cell Phenotypic Changes in Patients With Marfan Syndrome

Eva Crosas‐Molist, Thayna Meirelles, Judit López‐Luque et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2015 · 145 citations · Full text

Life Sciences, Cardiology, Cell Biology +15

Early Multinational Experience of Transcatheter Tricuspid Valve Replacement for Treating Severe Tricuspid Regurgitation

Rebecca T. Hahn, Susheel Kodali, Neil Fam et al. · JACC: Cardiovascular Interventions · 2020 · 122 citations · Full text

Medicine, Cardiology, Surgery +11

Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome

Gisela Teixidó‐Turà, Alberto Forteza, José F. Rodríguez‐Palomares et al. · Journal of the American College of Cardiology · 2018 · 108 citations · Full text

Medicine, Cardiology, Pharmacotherapy +12

Relationship between fibrillin-1 genotype and severity of cardiovascular involvement in Marfan syndrome

Romy Franken, Gisela Teixidó‐Turà, Marı́a Brión et al. · Heart · 2017 · 103 citations · Full text

Medicine, Cardiology, Genetics +16